Related Experiment Video
Updated: May 23, 2025
08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
2.5K
[Shared Decision-Making in Chronic Inflammatory Demyelinating Polyradiculoneuropathy]
Yukari Sekiguchi1, Sonoko Misawa
1Department of Neurology, JR Tokyo General Hospital.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|March 10, 2025
Summary
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) presents varied symptoms, necessitating tailored maintenance therapies like immunoglobulin. Shared decision-making and clear patient explanations are crucial for effective, individualized CIDP management.
Area of Science:
- Neurology
- Immunology
Context:
- Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a complex neurological disorder with diverse patient presentations and disease courses.
- Current management strategies include maintenance therapies, such as intravenous and subcutaneous immunoglobulin, requiring ongoing outpatient care.
Purpose:
- To outline key considerations for explaining CIDP to patients.
- To emphasize the importance of shared decision-making in treatment planning for CIDP.
Summary:
- CIDP encompasses a range of pathologies, leading to non-uniform patient symptoms and progression.
- Effective management hinges on detailed disease explanation and collaborative decision-making between clinician and patient.
- Maintenance therapies like immunoglobulin necessitate continuous outpatient monitoring and care.
Impact:
- Facilitates improved patient understanding and engagement in their CIDP treatment.
- Supports the implementation of personalized therapeutic approaches for CIDP patients.
- Enhances the quality of care for individuals with chronic inflammatory demyelinating polyradiculoneuropathy.
